Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 272

1.

Association of the Pro12Ala polymorphism in peroxisome proliferator-activated receptor gamma2 with decreased basic metabolic rate in women with polycystic ovary syndrome.

Koika V, Marioli DJ, Saltamavros AD, Vervita V, Koufogiannis KD, Adonakis G, Decavalas G, Georgopoulos NA.

Eur J Endocrinol. 2009 Aug;161(2):317-22. doi: 10.1530/EJE-08-1014. Epub 2009 May 22.

PMID:
19465486
3.

Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma gene in women with polycystic ovary syndrome.

Yilmaz M, Ergün MA, Karakoç A, Yurtçu E, Cakir N, Arslan M.

Gynecol Endocrinol. 2006 Jun;22(6):336-42.

PMID:
16785159
4.

Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma gene in first-degree relatives of subjects with polycystic ovary syndrome.

Yilmaz M, Ergün MA, Karakoç A, Yurtçu E, Yetkin I, Ayvaz G, Cakir N, Arslan M.

Gynecol Endocrinol. 2005 Oct;21(4):206-10.

PMID:
16316841
5.

Peroxisome proliferator activated receptor gamma gene variants influence susceptibility and insulin related traits in Indian women with polycystic ovary syndrome.

Shaikh N, Mukherjee A, Shah N, Meherji P, Mukherjee S.

J Assist Reprod Genet. 2013 Jul;30(7):913-21. doi: 10.1007/s10815-013-0025-y. Epub 2013 Jun 9.

6.

The peroxisome proliferator activated receptor gamma Pro12Ala polymorphism is associated with a lower hirsutism score and increased insulin sensitivity in women with polycystic ovary syndrome.

Hahn S, Fingerhut A, Khomtsiv U, Khomtsiv L, Tan S, Quadbeck B, Herrmann BL, Knebel B, Müller-Wieland D, Mann K, Janssen OE.

Clin Endocrinol (Oxf). 2005 May;62(5):573-9.

PMID:
15853827
7.
8.
9.

Lack of an association between peroxisome proliferator-activated receptor-gamma gene Pro12Ala polymorphism and adiponectin levels in the polycystic ovary syndrome.

Orio F Jr, Palomba S, Cascella T, Di Biase S, Labella D, Russo T, Savastano S, Zullo F, Colao A, Vettor R, Lombardi G.

J Clin Endocrinol Metab. 2004 Oct;89(10):5110-5.

PMID:
15472214
10.

A meta-analysis on the association between PPAR-γ Pro12Ala polymorphism and polycystic ovary syndrome.

He J, Wang L, Liu J, Liu F, Li X.

J Assist Reprod Genet. 2012 Jul;29(7):669-77. doi: 10.1007/s10815-012-9772-4. Epub 2012 Apr 21.

11.

The Pro12Ala polymorphism of the PPAR-gamma gene is not associated with the polycystic ovary syndrome.

Xita N, Lazaros L, Georgiou I, Tsatsoulis A.

Hormones (Athens). 2009 Oct-Dec;8(4):267-72.

12.

Increased frequency of the DI genotype of the angiotensin-I converting enzyme and association of the II genotype with insulin resistance in polycystic ovary syndrome.

Koika V, Georgopoulos NA, Piouka A, Roupas ND, Karela A, Armeni AK, Katsantoni E, Panidis D.

Eur J Endocrinol. 2012 Apr;166(4):695-702. doi: 10.1530/EJE-11-0894. Epub 2012 Jan 5.

PMID:
22223701
13.

Pro12Ala PPAR gamma2 gene polymorphism in women with polycystic ovary syndrome.

Bidzińska-Speichert B, Lenarcik A, Tworowska-Bardzińska U, Slezak R, Bednarek-Tupikowska G, Milewicz A, Krepuła K.

Ginekol Pol. 2011 Jun;82(6):426-9.

PMID:
21853931
14.

Pro12Ala PPAR γ2 gene polymorphism in PCOS women: the role of compounds regulating satiety.

Bidzińska-Speichert B, Lenarcik A, Tworowska-Bardzińska U, Slęzak R, Bednarek-Tupikowska G, Milewicz A.

Gynecol Endocrinol. 2012 Mar;28(3):195-8. doi: 10.3109/09513590.2011.593670. Epub 2011 Aug 10.

PMID:
21827375
15.

Peroxisome proliferator-activated receptor-γ and -δ polymorphisms in women with polycystic ovary syndrome.

Christopoulos P, Mastorakos G, Gazouli M, Deligeoroglou E, Katsikis I, Diamanti-Kandarakis E, Panidis D, Creatsas G.

Ann N Y Acad Sci. 2010 Sep;1205:185-91. doi: 10.1111/j.1749-6632.2010.05647.x.

PMID:
20840271
16.

Peroxisome proliferator-activated receptor-gamma and its coactivator-1alpha gene polymorphisms in Korean women with polycystic ovary syndrome.

Chae SJ, Kim JJ, Choi YM, Kim JM, Cho YM, Moon SY.

Gynecol Obstet Invest. 2010;70(1):1-7. doi: 10.1159/000279309. Epub 2010 Feb 2.

PMID:
20130411
17.

Basal metabolic rate is decreased in women with polycystic ovary syndrome and biochemical hyperandrogenemia and is associated with insulin resistance.

Georgopoulos NA, Saltamavros AD, Vervita V, Karkoulias K, Adonakis G, Decavalas G, Kourounis G, Markou KB, Kyriazopoulou V.

Fertil Steril. 2009 Jul;92(1):250-5. doi: 10.1016/j.fertnstert.2008.04.067. Epub 2008 Aug 3.

PMID:
18678372
18.

Association of MEP1A gene variants with insulin metabolism in central European women with polycystic ovary syndrome.

Lam UD, Lerchbaum E, Schweighofer N, Trummer O, Eberhard K, Genser B, Pieber TR, Obermayer-Pietsch B.

Gene. 2014 Mar 10;537(2):245-52. doi: 10.1016/j.gene.2013.12.055. Epub 2014 Jan 2.

PMID:
24388959
19.

No association of the G972S polymorphism of the insulin receptor substrate-1 gene with polycystic ovary syndrome in lean PCOS women with biochemical hyperandrogenemia.

Marioli DJ, Koika V, Adonakis GL, Saltamavros AD, Karela A, Armeni AK, Tsapanos VS, Decavalas GO, Georgopoulos NA.

Arch Gynecol Obstet. 2010 Jun;281(6):1045-9. doi: 10.1007/s00404-009-1299-2. Epub 2009 Dec 11.

PMID:
20012307
20.

Androgen levels and metabolic parameters are associated with a genetic variant of F13A1 in women with polycystic ovary syndrome.

Schweighofer N, Lerchbaum E, Trummer O, Schwetz V, Pilz S, Pieber TR, Obermayer-Pietsch B.

Gene. 2012 Aug 1;504(1):133-9. doi: 10.1016/j.gene.2012.04.050. Epub 2012 Apr 28.

PMID:
22565190

Supplemental Content

Support Center